Nuvalent (NUVL) Other financing activities (2021 - 2023)
Nuvalent (NUVL) posted Other financing activities of $13.6 million for Q4 2023, up 3292.49% on a QoQ basis from -$426000.0 in Q2 2023, and up 1003.0% year-over-year from $1.2 million in Q4 2022.
Nuvalent (NUVL) Other financing activities (2021 - 2023) Analysis & Trends
Nuvalent's Other financing activities history runs 3 years deep, the most recent figure standing at $13.6 million for Q4 2023.
- Quarterly Other financing activities rose 1003.0% year-over-year to $13.6 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $13.8 million (up 649.62% YoY) and the FY2023 annual result came in at $13.8 million, up 649.62% from the prior year.
- Other financing activities was $13.6 million for Q4 2023 at Nuvalent, up from -$426000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $177.3 million in Q3 2021 and bottomed at -$177.3 million in Q4 2021.
- A 3-year average of $1.7 million and a median of $394000.0 in 2022 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 4661.54% in 2023, while the deepest fall reached 313.0% in 2023.
- Nuvalent's Other financing activities stood at -$177.3 million in 2021, then jumped by 100.7% to $1.2 million in 2022, then soared by 1003.0% to $13.6 million in 2023.
- Business Quant data shows NUVL's Other financing activities at $13.6 million in Q4 2023, -$426000.0 in Q2 2023, and $619000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 13.60 Mn |
| Dec 31, 2023 | 13.60 Mn |
| Jun 30, 2023 | -426,000.00 |
| Jun 30, 2023 | -426,000.00 |
| Mar 31, 2023 | 619,000.00 |
| Mar 31, 2023 | 619,000.00 |
| Dec 31, 2022 | 1.23 Mn |
| Dec 31, 2022 | 1.23 Mn |
| Sep 30, 2022 | 394,000.00 |
| Sep 30, 2022 | 394,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Mar 31, 2022 | 13,000.00 |
| Mar 31, 2022 | 13,000.00 |
| Dec 31, 2021 | -177.26 Mn |
| Dec 31, 2021 | -177.26 Mn |
| Sep 30, 2021 | 177.27 Mn |
| Sep 30, 2021 | 177.27 Mn |